THE HEMATOLOGY DIAGNOSTICS MARKET SIZE WAS VALUED AT USD 3,384.34 MILLION IN 2021 AND IS EXPECTED TO REACH USD 4,409.22 MILLION BY 2027, GROWING AT A CAGR OF 4.51% DURING THE FORECAST PERIOD

Hematology Diagnostics Market Research Report Includes Size, Share, & Trends Analysis by Product (Consumables and Analyzer), Analyzer-Part (5&6 Part and 3-Part), Analyzer Volume (Small & Medium Volume and High Volume), Tests (Routine and Speciality), End-user (Hospitals, Standard Laboratory, Blood Banks, and Others), and By Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

346 Pages

icon-table

112 Tables

icon-chart

172 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

42 Companies

icon-market

6 Market Segment

HEMATOLOGY DIAGNOSTICS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 4,409.22 MILLION (2027)
CAGR 4.51 % (2022-2027)
BASE YEAR 2021
FORECAST YEAR 2022-2027
MARKET SEGMENTS By Product (Consumables and Analyzer), Analyzer-Part (5&6 Part and 3-Part), Analyzer Volume (Small & Medium Volume and High Volume)), Tests (Routine and Speciality), and End-user (Hospitals, Standard Laboratory, Blood Banks, and Others)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa

HEMATOLOGY DIAGNOSTICS MARKET OVERVIEW 

The hematology diagnostics market size was valued at USD 3,384.34 million in 2021 and is expected to reach USD 4,409.22 million by 2027, growing at a CAGR of 4.51% during the forecast period. The industry growth can be attributed to the high prevalence/incidence of several acute, chronic, and infectious diseases, especially blood-related ailments. An increased number of programmed parameters in the hematology analyzers have increased their scope of usage in various new health condition diagnostics. The conventional methods are very expensive for the rare blood-related disorders in the market. There is a huge scope for hematology testing in the new disease conditions. 

KEY HIGHLIGHTS 

  • At least once in a lifetime, 70% of the population will undergo the CBC test. The scope of CDC is increasing for various new diagnostics which will drive the hematology testing market growth.  
  • Due to the shortage of physicians and other benefits through the telehealth platforms, the hospitals are largely adopting telehealth. This scenario has a major impact on the hematology market. The doctors prescribe the tests, the patients are preferring to undergo tests in the nearby smaller diagnostic labs or physician offices and share the results in the telehealth platform. 
  • The automation in the analyzers has revolutionized the hematology testing by the reduction in time and the increase in the accuracy of the diagnosis. Along with the technological advancements, the regents used for the analyzers are also evolving with longer shelf life and overcoming the challenges in the market. 
  • Sysmex, one of the Japanese company came up with a concentrated reagent for the hematology analyzers. These concentrated reagents are gaining traction in the market, especially in developed countries. 

HEMATOLOGY DIAGNOSTICS MARKET SEGMENTS 

This research report has the following segmentation: 

  • Product
  • Analyzer Part 
  • Analyzer volume 
  • Tests 
  • End-user 
  • Geography 

HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION 

  • The usage of 5-part hematology analyzers is increasing because there is a huge demand for automated analyzers which provides the readymade results for various programmed parameters required in the lab. 
  • Routine hematology tests performed are increasing over time. The parameters checked in the routine hematology tests are used for various health conditions. Development in technological advancements has led to an understanding of the relationship between routine tests and various disease indications. This has increased the number of routine tests performed in the world. 
  • In the hospital segment, the private diagnostic chains are taking the lead slowly in most of the developing and developed countries. Their results are providing superior and quality services with a better test menu, this is helping them to gain the market share. 

GEOGRAPHICAL ANALYSIS 

  • North America: The demand is mainly growing across the professional healthcare settings to treat the rising patient population. Moreover, an increase in the prevalence of various blood-related disorders such as anemia, sickle cell disease, and thalassemia, especially in the US and Canada as well as the growing requirement for hematology testing is boosting the demand for hematology analyzers and consumables. 
  • Europe: The demand for advanced and fully automated hematology analyzers is expected to increase due to the rise in the prevalence of the target population requiring hematological tests, increased focus on technological advancements, the shift towards automation in hematology analyzers. In addition, Western Europe has the access to advanced healthcare services, especially for the diagnosis facility. The per capita healthcare expenditure is high in that area, thereby, indirectly fuelling the hematology diagnostics market. 

VENDOR LANDSCAPE 

  • The key players in the hematology diagnostics market are Abbott, Boule Diagnostics, Horiba, Sysmex, Shenzhen Mindray Bio-Medical Electronics, Siemens Healthineers, Nihon Kohden, Diatron, Danaher. 
  • Companies are strengthening their product portfolio by the inorganic growth. For instance, Abbot acquired St. Jude Medical in the year 2017, which made it develop a portfolio of devices for diagnostics and other segments this helps them to increase their share in the hematology market. 
  • Sysmex is the only pure player which is highly active in the market. In 2018, they began selling their first product to have received CLIA-waiver certification to clinics and other small-scale facilities in the US. 
  • Major and emerging players are actively launching innovative devices to penetrate and tap the huge growth potential prevailing in the industry. 
  • Boule Diagnostics is one of the very few pure players in the global hematology diagnostics market, dedicated its expertise in developing and manufacturing analyzers and related consumables for hematology testing, and has a very strong footprint in the hematology diagnostics market. 

The hematology diagnostics market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments: 

By Product 

  • Consumables 
  • Analyzer 

By Analyzer-Part 

  • 5&6 Part 
  • 3-Part 

By Analyzer-Volume 

  • Small & Medium Volume 
  • High Volume 

By Tests 

  • Routine 
  • Speciality 

By End-user 

  • Hospitals 
  • Standard Laboratory 
  • Blood Banks 
  • Others 

By Geography 

  • North America 
  • US 
  • Canada 
  • Europe 
  • Germany 
  • France 
  • UK 
  • Italy 
  • Spain 
  • APAC 
  • China 
  • Japan 
  • India 
  • South Korea 
  • Australia 
  • Latin America 
  • Brazil 
  • Mexico 
  • Argentina 
  • Middle East & Africa 
  • Turkey 
  • Saudi Arabia 
  • South Africa 

Frequently Asked Questions

What is the size of the hematology diagnostics market?

The hematology diagnostics market size was valued at USD 3,384.34 million in 2021 and is expected to reach USD 4,409.22 million by 2027.

What are the latest trends in the global hematology diagnostics market?

The latest trends in the global hematology diagnostic market are artificial intelligence, increased adoption of telehealth, integration of flow-cytometry with hematology analysers increasing blood transfusions & donations, etc.

Which region has the highest share in the hematology testing market?

North America region has the highest share in the hematology testing market

Who are the end-users in the hematology testing market?

The end-users in the hematology testing market are hospitals, standard laboratory blood banks, and others.

Who are the key players in the hematology diagnostics market?

The key players in the hematology diagnostics market are Abbott, Boule Diagnostics, Horiba, Sysmex, Shenzhen Mindray, Siemens healthiness, NIHON KOHDEN, Diatron, Danaher, etc.

Download Free Sample

The hematology diagnostics market size was valued at USD 3,384.34 million in 2021 and is expected to reach USD 4,409.22 million by 2027, growing at a CAGR of 4.51% during the forecast period

The following factors are likely to contribute to the growth of the hematology diagnostics market –

  • Artificial Intelligence in Hematology Testing
  • Increase in Demand for Point of Care Hematology Testing
  • Technological Advancements in Hematology Testing
  • Increased Adoption of Telehealth
  • Increasing Product Launches
  • Integration of Flow-Cytometry with Hematology Analysers
  • Increasing Blood Transfusions & Donations

Base Year: 2021

Forecast Year: 2022-2027

The study considers a detailed scenario of the present hematology testing market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Key Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Boule Diagnostics
  • Horiba
  • Sysmex
  • Shenzhen Mindray Bio-Medical Electronics
  • Siemens Healthineers
  • Nihon Kohden
  • Diatron
  • Danaher

Other Prominent Vendors

  • Alpha Scientific
    • Business Overview
    • Product Offerings
  • Agappe Diagnostics
  • Analyticon Biotechnologies
  • Balio Diagnostics
  • B&E BIO-TECHNOLOGY
  • Biosystems
  • Bioway Biological Technology
  • Bio-Rad Laboratories
  • Clindiag Systems
  • Contec Medical Systems 
  • Convergent Technologies
  • CPC Diagnostics
  • CPM Scientifica
  • Diagon
  • DIRUI
  • Drucker Diagnostics
  • Erba Diagnostics
  • EDAN Instruments
  • F.Hoffmann-La Roche
  • Genrui Biotech
  • High Technology
  • Shenzhen Landwind Medical
  • Linear Chemicals
  • Maccura Biotechnology
  • Meril Life Sciences
  • Norma
  • Prestige Diagnostics
  • SFRI
  • Shenzhen Dymind Biotechnology
  • Shenzhen iCubio Biomedical Technology
  • SHENZHEN PROKAN ELECTRONICS
  • Spinreact
  • Trivitron Healthcare

Market Segmentation by Product

  • Consumables
  • Analyzer

Market Segmentation by Analyzer-Part

  • 5&6 Part
  • 3-Part

Market Segmentation by Analyzer-Volume

  • Small & Medium Volume
  • High Volume

Market Segmentation by Tests

  • Routine
  • Speciality

Market Segmentation by End-user

  • Hospitals
  • Standard Laboratory
  • Blood Banks
  • Others

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

 

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1        Market Definition

4.01.01 Inclusions

4.01.02 Exclusions

4.01.03 Market Estimation Caveats

4.2        Base Year

4.3        Scope Of The Study

4.03.01 Market Segment By Product

4.03.02 Market Segment By Test Type

4.03.03 Market Segment By End-User

4.03.04 Market Segmentation By Geography

 

5            Report Assumptions & Caveats

5.1        Key Caveats

5.2        Currency Conversion

5.3        Market Derivation

 

6            Market At A Glance

7            Introduction

7.1        Overview

7.2        Impact Of Covid-19 On Hematology Testing

7.02.01 Covid-19 An Opportunity For Hematology Testing

 

8            Market Opportunities & Trends

8.1        Artificial Intelligence In Hematology Testing

8.2        Increase In Demand For Point-Of-Care Hematology Testing

8.3        Technological Advancements In Hematology Testing

8.4        Increased Adoption Of Telehealth

 

9            Market Growth Enablers

9.1        Increasing Product Launches

9.2        Integration Of Flow Cytometry With Hematology Analyzers

9.3        Increasing Blood Transfusions & Donations

 

10         Market Restraints

10.1      Stringent Regulations Coupled With Product Recalls & Safety Concerns

10.2      High Initial Investment & Maintenance Of Hematology Analyzers

10.3      Lower-Than-Expected Penetration Of Advanced Hematology Analyzers In LMICS

 

11         Market Landscape

11.1      Market Overview

11.2      Market Size & Forecast

11.3      Five Forces Analysis

11.03.01             Threat Of New Entrants

11.03.02             Bargaining Power Of Suppliers

11.03.03             Bargaining Power Of Buyers

11.03.04             Threat Of Substitutes

11.03.05             Competitive Rivalry

 

12         Product

12.1      Market Snapshot & Growth Engine

12.2      Market Overview

12.3      Consumables

12.03.01             Market Overview

12.03.02             Market Size & Forecast

12.03.03             Consumables – Geography Segmentation

12.4      Analyzers

12.04.01             Market Overview

12.04.02             Market Size & Forecast

12.04.03             Analyzers – Geography Segmentation

 

13         Analyzers – Part Differential

13.1      Market Snapshot & Growth Engine

13.2      Market Overview

13.3      5&6-Part

13.03.01             Market Overview

13.03.02             Market Size & Forecast

13.03.03             5&6-Part Hematology Analyzers – Geography Segmentation

13.4      3-PART

13.04.01             Market Overview

13.04.02             Market Size & Forecast

13.04.03             3-Part Hematology Analyzers – Geography Segmentation

 

14         Analyzers – Volume

14.1      Market Snapshot & Growth Engine

14.2      Market Overview

14.3      Small & Medium Volume

14.03.01             Market Overview

14.03.02             Market Size & Forecast

14.03.03             Small & Medium Volume – Geography Segmentation

14.4      High Volume

14.04.01             Market Overview

14.04.02             Market Size & Forecast

14.04.03             High Volume – Geography Segmentation

 

15         Test

15.1      Market Snapshot & Growth Engine

15.2      Market Overview

15.3      Routine Tests

15.03.01             Market Overview

15.03.02             Market Size & Forecast

15.03.03             Routine Tests – Geography Segmentation

15.4      Specialty Tests

15.04.01             Market Overview

15.04.02             Market Size & Forecast

15.04.03             Specialty Tests – Geography Segmentation

 

16         End-User

16.1      Market Snapshot & Growth Engine

16.2      Market Overview

16.3      Hospitals

16.03.01             Market Overview

16.03.02             Market Size & Forecast

16.03.03             Hospitals – Geography Segmentation

16.4      Standard Reference Laboratories

16.04.01             Market Overview

16.04.02             Market Size & Forecast

16.04.03             Standard Reference Laboratories – Geography Segmentation

16.5      Blood Bank

16.05.01             Market Overview

16.05.02             Market Size & Forecast

16.05.03             Blood Banks – Geography Segmentation

16.6      Others

16.06.01             Market Overview

16.06.02             Market Size & Forecast

16.06.03             Others – Geography Segmentation

 

17         Geography

17.1      Market Snapshot & Growth Engine

17.2      Geographic Overview

18         North America

18.1      Market Overview

18.2      Market Size & Forecast

18.3      North America: Product

18.4      North America: Analyzer – Part Differential

18.5      North America: Analyzer – Volume

18.6      North America: Test

18.7      North America: End-User

18.8      Key Countries

18.08.01             US: Market Size & Forecast

18.08.02             Canada: Market Size & Forecast

 

19         Europe

19.1      Market Overview

19.2      Market Size & Forecast

19.3      Europe: Product

19.4      Europe: Analyzer – Part Differential

19.5      Europe: Analyzer – Volume

19.6      Europe: Test

19.7      Europe: End-User

19.8      Key Countries

19.08.01             Germany: Market Size & Forecast

19.08.02             France: Market Size & Forecast

19.08.03             UK: Market Size & Forecast

19.08.04             Italy: Market Size & Forecast

19.08.05             Spain: Market Size & Forecast

 

20         APAC

20.1      Market Overview

20.2      Market Size & Forecast

20.3      APAC: Product

20.4      APAC: Analyzer – Part Differential

20.5      APAC: Analyzer – Volume

20.6      APAC: TEST

20.7      APAC: END-USER

20.8      Key Countries

20.08.01             China: Market Size & Forecast

20.08.02             Japan: Market Size & Forecast

20.08.03             India: Market Size & Forecast

20.08.04             South Korea: Market Size & Forecast

20.08.05             Australia: Market Size & Forecast

 

21         Latin America

21.1      Market Overview

21.2      Market Size & Forecast

21.3      Latin America: Product

21.4      Latin America: Analyzer – Part Differential

21.5      Latin America: Analyzer – Volume

21.6      Latin America: Test

21.7      Latin America: End-User

21.8      Key Countries

21.08.01             Brazil: Market Size & Forecast

21.08.02             Mexico: Market Size & Forecast

21.08.03             Argentina: Market Size & Forecast

 

22         Middle East & Africa

22.1      Market Overview

22.2      Market Size & Forecast

22.3      Middle East & Africa: Product

22.4      Middle East & Africa: Analyzer – Part Differential

22.5      Middle East & Africa: Analyzer – Volume

22.6      Middle East & Africa: Test

22.7      Middle East & Africa: End-User

22.8      Key Countries

22.08.01             Turkey: Market Size & Forecast

22.08.02             Saudi Arabia: Market Size & Forecast

22.08.03             South Africa: Market Size & Forecast

 

23         Competitive Landscape

23.1      Competition Overview

23.2      Market Share Analysis

23.02.01             Abbott

23.02.02             Boule Diagnostics

23.02.03             Danaher

23.02.04             Diatron

23.02.05             HORIBA

23.02.06             NIHON KOHDEN

23.02.07             SHENZEN MINDRAY BIO-MEDICAL ELECTRONICS

23.02.08             Siemens Healthineers

23.02.09             Sysmex

 

24         Key Company Profiles

24.1      ABBOTT

24.01.01             Business Overview

24.01.02             Product Offerings

24.01.03             Key Strategies

24.01.04             Key Strengths

24.01.05             Key Opportunities

24.2      BOULE DIAGNOSTICS

24.02.01             Business Overview

24.02.02             Product Offerings

24.02.03             Key Strategies

24.02.04             Key Strengths

24.02.05             Key Opportunities

24.3      DANAHER

24.03.01             Business Overview

24.03.02             Product Offerings

24.03.03             Key Strategies

24.03.04             Key Strengths

24.03.05             Key Opportunities

24.4      DIATRON

24.04.01             Business Overview

24.04.02             Product Offerings

24.04.03             Key Strategies

24.04.04             Key Strengths

24.04.05             Key Opportunities

24.5      HORIBA

24.05.01             Business Overview

24.05.02             Product Offerings

24.05.03             Key Strategies

24.05.04             Key Strengths

24.05.05             Key Opportunities

24.6      NIHON KOHDEN

24.06.01             Business Overview

24.06.02             Product Offerings

24.06.03             Key Strategies

24.06.04             Key Strengths

24.06.05             Key Opportunities

24.7      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS

24.07.01             Business Overview

24.07.02             Product Offerings

24.07.03             Key Strategies

24.07.04             Key Strengths

24.07.05             Key Opportunities

24.8      SIEMENS HEALTHINEERS

24.08.01             Business Overview

24.08.02             Product Offerings

24.08.03             Key Strategies

24.08.04             Key Strengths

24.08.05             Key Opportunities

24.9      SYSMEX

24.09.01             Business Overview

24.09.02             Product Offerings

24.09.03             Key Strategies

24.09.04             Key Strengths

24.09.05             Key Opportunities

 

25         Other Prominent Vendors

25.1      ALPHA SCIENTIFIC

25.01.01             Business Overview

25.01.02             Product Offerings

25.2      AGAPPE DIAGNOSTICS

25.02.01             Business Overview

25.02.02             Product Offerings

25.3      ANALYTICON BIOTECHNOLOGIES

25.03.01             Business Overview

25.03.02             Product Offerings

25.4      BALIO DIAGNOSTICS

25.04.01             Business Overview

25.04.02             Product Offerings

25.5      B&E BIO-TECHNOLOGY

25.05.01             Business Overview

25.05.02             Product Offerings

25.6      BIOSYSTEMS

25.06.01             Business Overview

25.06.02             Product Offerings

25.7      BIOWAY BIOLOGICAL TECHNOLOGY

25.07.01             Business Overview

25.07.02             Product Offerings

25.8      BIO-RAD

25.08.01             Business Overview

25.08.02             Product Offerings

25.9      CLINDIAG SYSTEMS

25.09.01             Business Overview

25.09.02             Product Offerings

25.10    CONTECH MEDICAL SYSTEMS

25.10.01             Business Overview

25.10.02             Product Offerings

25.11    CONVERGENT TECHNOLOGIES

25.11.01             Business Overview

25.11.02             Product Offerings

25.12    CPC DIAGNOSTICS

25.12.01             Business Overview

25.12.02             Product Offerings

25.13    CPM SCIENTIFICA

25.13.01             Business Overview

25.13.02             Product Offerings

25.14    DIAGON

25.14.01             Business Overview

25.14.02             Product Offerings

25.15    DIRUI

25.15.01             Business Overview

25.15.02             Product Offerings

25.16    DRUCKER DIAGNOSTICS

25.16.01             Business Overview

25.16.02             Product Offerings

25.17    ERBA DIAGNOSTICS

25.17.01             Business Overview

25.17.02             Product Offerings

25.18    EDAN INSTRUMENTS

25.18.01             Business Overview

25.18.02             Product Offerings

25.19    F. HOFFMANN-LA ROCHE

25.19.01             Business Overview

25.19.02             Product Offerings

25.20    GENRUI BIOTECH

25.20.01             Business Overview

25.20.02             Product Offerings

25.21    HIGH TECHNOLOGY

25.21.01             Business Overview

25.21.02             Product Offerings

25.22    SHENZHEN LANDWIND MEDICAL

25.22.01             Business Overview

25.22.02             Product Offerings

25.23    LINEAR CHEMICALS

25.23.01             Business Overview

25.23.02             Product Offerings

25.24    MACCURA BIOTECHNOLOGY

25.24.01             Business Overview

25.24.02             Product Offerings

25.25    MERIL LIFESCIENCES

25.25.01             Business Overview

25.25.02             Product Offerings

25.26    NORMA

25.26.01             Business Overview

25.26.02             Product Offerings

25.27    PRESTIGE DIAGNOSTICS

25.27.01             Business Overview

25.27.02             Product Offerings

25.28    SFRI

25.28.01             Business Overview

25.28.02             Product Offerings

25.29    SHENZHEN DYMIND BIOTECHNOLOGY

25.29.01             Business Overview

25.29.02             Product Offerings

25.30    SHENZHEN ICUBIO BIOMEDICAL TECHNOLOGY

25.30.01             Business Overview

25.30.02             Product Offerings

25.31    SHENZHEN PROKAN ELECTRONICS

25.31.01             Business Overview

25.31.02             Product Offerings

25.32    SPINREACT

25.32.01             Business Overview

25.32.02             Product Offerings

25.33    TRIVITRON HEALTHCARE

25.33.01             Business Overview

25.33.02             Product Offerings

 

26         Report Summary

26.1      Key Takeaways

26.2      Strategic Recommendations

 

27         Quantitative Summary

27.1      Market By Geography

27.2      Market By End-User

27.3      Market By Test

27.4      Market By Product

27.5      Market By Analyzers – Volume

27.6      Market By Analyzers – Part Differential

27.7      North America: End-User

27.8      North America: Test

27.9      North America: Product

27.10    North America: Analyzers – Volume

27.11    North America: Analyzers – Part Differential

27.12    Europe: End-User

27.13    Europe: Test

27.14    Europe: Product

27.15    Europe: Analyzers – Volume

27.16    Europe: Analyzers – Part Differential

27.17    APAC: End-User

27.18    APAC: Test

27.19    APAC: Product

27.20    APAC: Analyzers – Volume

27.21    APAC: Analyzers – Part Differential

27.22    Latin America: End-User

27.23    Latin America: Test

27.24    Latin America: Product

27.25    Latin America: Analyzers – Volume

27.26    Latin America: Analyzers – Part Differential

27.27    Middle East & Africa: End-User

27.28    Middle East & Africa: Test

27.29    Middle East & Africa: Product

27.30    Middle East & Africa: Analyzers – Volume

27.31    Middle East & Africa: Analyzers – Part Differential

 

28         Appendix

28.1      Abbreviations

Exhibit 1             Segmentation of the Global Hematology Testing Market

Exhibit 2             Market Size Calculation Approach 2021

Exhibit 3             Hematology Testing Market – Driving Factors

Exhibit 4             Impact of Artificial Intelligence in Hematology Testing

Exhibit 5             Impact of Increase in Demand for Point-of-Care Hematology Testing

Exhibit 6             Impact of Technological Advancements in Hematology Testing

Exhibit 7             Impact of Increased Adoption of Telehealth

Exhibit 8             Specialists’ Willingness to Adopt Telehealth

Exhibit 9             Usage of Telehealth Prior To and Following the COVID-19 pandemic

Exhibit 10           Adoption of Telehealth in US Hospitals 2010–2017

Exhibit 11           Impact of Increasing Product Launches

Exhibit 12           Impact of Integration of Flow Cytometry with Hematology Analyzers

Exhibit 13           Impact of Increasing Blood Transfusions & Donations

Exhibit 14           Blood Donation Rate in Different Countries – 2018 & 2025

Exhibit 15           Impact of Stringent Regulations Coupled with Product Recalls & Safety Concerns

Exhibit 16           Impact of High Initial Investment & Maintenance of Hematology Analyzers

Exhibit 17           Impact of Lower-Than-Expected Penetration of Advanced Hematology Analyzers in LMICs

Exhibit 18           Global Hematology Testing Market 2021–2027 ($ million)

Exhibit 19           Global Hematology Testing Market by Product (%)

Exhibit 20           Global Hematology Testing Market by Test (%)

Exhibit 21           Global Hematology Testing Market by End-User (%)

Exhibit 22           Global Hematology Testing Market by Geography (%)

Exhibit 23           Five Forces Analysis 2021

Exhibit 24           Incremental Growth by Product 2021 & 2027

Exhibit 25           Global Hematology Testing Market by Product

Exhibit 26           Global Hematology Testing Market by Product: Incremental Growth ($ million)

Exhibit 27           Global Hematology Testing Market by Product: Absolute Growth

Exhibit 28           Global Hematology Testing Consumables Market: Incremental Growth & Absolute Growth

Exhibit 29           Global Hematology Testing Consumables Market 2021–2027 ($ million)

Exhibit 30           Incremental Growth by Geography 2021 & 2027

Exhibit 31           Global Hematology Testing Market by Analyzers

Exhibit 32           Global Hematology Testing Analyzers Market: Incremental Growth & Absolute Growth

Exhibit 33           Global Hematology Testing Analyzers Market 2021–2027 ($ million)

Exhibit 34           Incremental Growth by Geography 2021 & 2027

Exhibit 35           Incremental Growth by Part Differential 2021 & 2027

Exhibit 36           Global Hematology Analyzers Market by Part Differential

Exhibit 37           Comparison of 3-Part Differential and 5-Part Differential Hematology Analyzers

Exhibit 38           Global 5&6-Part Hematology Analyzers Market: Incremental Growth & Absolute Growth

Exhibit 39           Global 5&6-Part Hematology Analyzers Market 2021–2027 ($ million)

Exhibit 40           Incremental Growth by Geography 2021 & 2027

Exhibit 41           Global 3-Part Hematology Analyzers Market: Incremental Growth & Absolute Growth

Exhibit 42           Global 3-Part Hematology Analyzers Market 2021–2027 ($ million)

Exhibit 43           Incremental Growth by Geography 2021 & 2027

Exhibit 44           Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 45           Global Hematology Analyzers Market by Volume

Exhibit 46           Global Small & Medium Volume Hematology Analyzers Market: Incremental Growth & Absolute Growth

Exhibit 47           Global Small & Medium Volume Hematology Analyzers Market 2021–2027 ($ million)

Exhibit 48           Incremental Growth by Geography 2021 & 2027

Exhibit 49           Global High-Volume Hematology Analyzers Market: Incremental Growth & Absolute Growth

Exhibit 50           Global High Volume Hematology Analyzers Market 2021–2027 ($ million)

Exhibit 51           Incremental Growth by Geography 2021 & 2027

Exhibit 52           Incremental Growth by Test 2021 & 2027

Exhibit 53           Global Hematology Testing Market by Test

Exhibit 54           List of Routine and Specialty Tests Performed

Exhibit 55           Global Hematology Testing Market by Test: Incremental Growth ($ million)

Exhibit 56           Global Hematology Testing Market by Test: Absolute Growth

Exhibit 57           CBC Test Count in the US (millions)

Exhibit 58           Global Hematology Routine Testing Market: Incremental Growth & Absolute Growth

Exhibit 59           Global Hematology Routine Testing Market 2021–2027 ($ million)

Exhibit 60           Incremental Growth by Geography 2021 & 2027

Exhibit 61           Global Hematology Specialty Testing Market: Incremental Growth & Absolute Growth

Exhibit 62           Global Population of People Suffering with Dementia (million)

Exhibit 63           Global Population of Malaria Patients (millions)

Exhibit 64           Global Hematology Specialty Testing Market 2021–2027 ($ million)

Exhibit 65           Incremental Growth by Geography 2021 & 2027

Exhibit 66           Incremental Growth by End-User 2021 & 2027

Exhibit 67           Global Hematology Testing Market by End-User

Exhibit 68           Diagnostic Industry Market Structure

Exhibit 69           Global Hematology Testing Market by End-User: Incremental Growth ($ million)

Exhibit 70           Global Hematology Testing Market by End-User: Absolute Growth

Exhibit 71           Global Hematology Testing Hospitals Market: Incremental Growth & Absolute Growth

Exhibit 72           Global Hematology Testing Hospitals Market 2021–2027 ($ million)

Exhibit 73           Incremental Growth by Geography 2021 & 2027

Exhibit 74           Global Hematology Testing Standard Reference Laboratories Market: Incremental Growth & Absolute Growth

Exhibit 75           Global Hematology Testing Standard Reference Laboratories Market 2021–2027 ($ million)

Exhibit 76           Incremental Growth by Geography 2021 & 2027

Exhibit 77           Global Hematology Testing Blood Bank Market: Incremental Growth & Absolute Growth

Exhibit 78           Global Hematology Testing Blood Bank Market 2021–2027 ($ million)

Exhibit 79           Incremental Growth by Geography 2021 & 2027

Exhibit 80           Global Hematology Testing Other End-Users Market: Incremental Growth & Absolute Growth

Exhibit 81           Global Hematology Testing Other End-Users Market 2021–2027 ($ million)

Exhibit 82           Incremental Growth by Geography 2021 & 2027

Exhibit 83           Incremental Growth by Geography 2021 & 2027

Exhibit 84           Global Hematology Testing Market by Geography

Exhibit 85           Global Hematology Testing Market- Historical Data ($ million)

Exhibit 86           Product Life Cycle in Various Regions

Exhibit 87           Global Hematology Testing Market by Geography: Incremental Growth ($ million)

Exhibit 88           Global Hematology Testing Market by Geography: Absolute Growth

Exhibit 89           North America Hematology Testing Market- Historical Data ($ million)

Exhibit 90           Hematology Testing Market in North America: Key Countries 2021 ($ million)

Exhibit 91           Hematology Testing Market in North America: Incremental Growth & Absolute Growth

Exhibit 92           Hematology Testing Market in North America 2021–2027 ($ million)

Exhibit 93           Incremental Growth by Product 2021 & 2027

Exhibit 94           Incremental Growth by Part Differential 2021 & 2027

Exhibit 95           Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 96           Incremental Growth by Test 2021 & 2027

Exhibit 97           Incremental Growth by End-User 2021 & 2027

Exhibit 98           Incremental Growth in North America 2021 & 2027

Exhibit 99           Testing Volumes in Various Healthcare Settings of the US

Exhibit 100        Hematology Testing Market in the US 2021–2027 ($ million)

Exhibit 101        Hematology Testing Market in Canada 2021–2027 ($ million)

Exhibit 102        Europe Hematology Testing Market- Historical Data ($ million)

Exhibit 103        Hematology Testing Market in Europe: Key Countries 2021 ($ million)

Exhibit 104        Hematology Testing Market in Europe: Incremental Growth & Absolute Growth

Exhibit 105        Hematology Testing Market in Europe 2021–2027 ($ million)

Exhibit 106        Incremental Growth by Product 2021 & 2027

Exhibit 107        Incremental Growth by Part Differential 2021 & 2027

Exhibit 108        Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 109        Incremental Growth by Test 2021 & 2027

Exhibit 110        Incremental Growth by End-User 2021 & 2027

Exhibit 111        Incremental Growth in Europe 2021 & 2027

Exhibit 112        Hematology Testing Market in Germany 2021–2027 ($ million)

Exhibit 113        Hematology Testing Market in France 2021–2027 ($ million)

Exhibit 114        Hematology Testing Market in the UK 2021–2027 ($ million)

Exhibit 115        Hematology Testing Market in Italy 2021–2027 ($ million)

Exhibit 116        Hematology Testing Market in Spain 2021–2027 ($ million)

Exhibit 117        APAC Hematology Testing Market- Historical Data ($ million)

Exhibit 118        Hematology Testing Market in APAC: Key Countries 2021 ($ million)

Exhibit 119        Hematology Testing Market in APAC: Incremental Growth & Absolute Growth

Exhibit 120        Hematology Testing Market in APAC 2021–2027 ($ million)

Exhibit 121        Incremental Growth by Product 2021 & 2027

Exhibit 122        Incremental Growth by Part Differential 2021 & 2027

Exhibit 123        Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 124        Incremental Growth by Test 2021 & 2027

Exhibit 125        Incremental Growth by End-User 2021 & 2027

Exhibit 126        Incremental Growth in APAC 2021 & 2027

Exhibit 127        Hematology Testing Market in China 2021–2027 ($ million)

Exhibit 128        Hematology Testing Market in Japan 2021–2027 ($ million)

Exhibit 129        Hematology Testing Market in India 2021–2027 ($ million)

Exhibit 130        Hematology Testing Market in South Korea 2021–2027 ($ million)

Exhibit 131        Hematology Testing Market in Australia 2021–2027 ($ million)

Exhibit 132        Hematology Testing Market in Latin America: Key Countries 2021 ($ million)

Exhibit 133        Latin America Hematology Testing Market- Historical Data ($ million)

Exhibit 134        Hematology Testing Market in Latin America: Incremental Growth & Absolute Growth

Exhibit 135        Hematology Testing Market in Latin America 2021–2027 ($ million)

Exhibit 136        Incremental Growth by Product 2021 & 2027

Exhibit 137        Incremental Growth by Part Differential 2021 & 2027

Exhibit 138        Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 139        Incremental Growth by Test 2021 & 2027

Exhibit 140        Incremental Growth by End-User 2021 & 2027

Exhibit 141        Incremental Growth in Latin America 2021 & 2027

Exhibit 142        Hematology Testing Market in Brazil 2021–2027 ($ million)

Exhibit 143        Hematology Testing Market in Mexico 2021–2027 ($ million)

Exhibit 144        Hematology Testing Market in Argentina 2021–2027 ($ million)

Exhibit 145        Middle East & Africa Hematology Testing Market- Historical Data ($ million)

Exhibit 146        Hematology Testing Market in the Middle East & Africa: Key Countries 2021 ($ million)

Exhibit 147        Hematology Testing Market in the Middle East & Africa: Incremental Growth & Absolute Growth

Exhibit 148        Hematology Testing Market in the Middle East & Africa 2021–2027 ($ million)

Exhibit 149        Incremental Growth by Product 2021 & 2027

Exhibit 150        Incremental Growth by Part Differential 2021 & 2027

Exhibit 151        Incremental Growth by Analyzer Volume 2021 & 2027

Exhibit 152        Incremental Growth by Test 2021 & 2027

Exhibit 153        Incremental Growth by End-User 2021 & 2027

Exhibit 154        Incremental Growth in the Middle East & Africa 2021 & 2027

Exhibit 155        Hematology Testing Market in Turkey 2021–2027 ($ million)

Exhibit 156        Hematology Testing Market in Saudi Arabia 2021–2027 ($ million)

Exhibit 157        Hematology Testing Market in South Africa 2021–2027 ($ million)

Exhibit 158        Competitive Structure Analysis of Hematology Testing Market

Exhibit 159        Global Hematology Testing Market: Competitors Grid Analysis

Exhibit 160        Global Hematology Testing Market Share - 2020

Exhibit 161        Abbott – Revenue 2018 to 2020 ($ million)

Exhibit 162        Abbott – Research & Development 2018 to 2020 ($ million)

Exhibit 163        Boule Diagnostics – Revenue 2018-2020 ($ million)

Exhibit 164        Danaher: Revenue by Segments ($ billion)

Exhibit 165        Danaher: Revenue 2018–2020 ($ million)

Exhibit 166        HORIBA – Medical Diagnostics Instruments & Systems 2019-2020 ($ million)

Exhibit 167        HORIBA Medical-Diagnostic Instruments & Systems Segment by Divisions 2019-2020 (%)

Exhibit 168        NIHON KOHDEN: Revenue ($ billion)

Exhibit 169        Siemens Healthineers: Revenue 2018–2020 ($ billion)

Exhibit 170        Sysmex – Revenue 2018-2020 ($ billion)

Exhibit 171        Sysmex – Revenue by Segment – 2019-2020 (%)

Exhibit 172        Sysmex – Revenue by Region – 2019-2020 (%)             

LIST OF TABLES

Table 1             Key Caveats

Table 2             Currency Conversion 2015−2021

Table 3             OLO Analyzer – Unique Features

Table 4              Recent Innovations in Hematology Diagnostics

Table 5               Key Product Launches in the Hematology Testing Market

Table 6               Recent Product Recalls in the Hematology Testing Market

Table 7               Cost Model of Various Hematology Analyzers

Table 8               Global Hematology Testing Market Vendors – Ranking

Table 9               Abbott: Major Product Offerings

Table 10             Boule Diagnostics: Major Product Offerings

Table 11             Danaher: Major Product Offerings

Table 12             Diatron: Major Product Offerings

Table 13             HORIBA: Major Product Offerings

Table 14             NIHON KOHDEN: Major Product Offerings

Table 15             Shenzhen Mindray Bio-Medical Electronics: Major Product Offerings

Table 16             Siemens Healthineers: Major Product Offerings

Table 17             Sysmex: Major Product Offerings

Table 18             ALPHA SCIENTIFIC: Major Product Offerings

Table 19             Agappe Diagnostics: Major Product Offerings

Table 20             Analyticon Biotechnologies: Major Product Offerings

Table 21             Balio Diagnostics: Major Product Offerings

Table 22             B&E BIO-TECHNOLOGY: Major Product Offerings

Table 23             Biosystems: Major Product Offerings

Table 24             Bioway Biological Technology: Major Product Offerings

Table 25             Bio-Rad: Major Product Offerings

Table 26             CLINDIAG SYSTEMS: Major Product Offerings

Table 27             CONTECH MEDICAL SYSTEMS: Major Product Offerings

Table 28             Convergent Technologies: Major Product Offerings

Table 29             CPC Diagnostics: Major Product Offerings

Table 30             CPM Scientifica: Major Product Offerings

Table 31             DIAGON: Major Product Offerings

Table 32             DIRUI: Major Product Offerings

Table 33             Drucker Diagnostics: Major Product Offerings

Table 34             Erba Diagnostics: Major Product Offerings

Table 35             EDAN Instruments: Major Product Offerings

Table 36             F. Hoffmann-La Roche: Major Product Offerings

Table 37             Genrui Biotech: Major Product Offerings

Table 38             High Technology: Major Product Offerings

Table 39             Shenzhen Landwind Medical: Major Product Offerings

Table 40             Linear Chemicals: Major Product Offerings

Table 41             Maccura Biotechnology: Major Product Offerings

Table 42             Meril Lifesciences: Major Product Offerings

Table 43             Norma: Major Product Offerings

Table 44             Prestige Diagnostics: Major Product Offerings

Table 45             SFRI: Major Product Offerings

Table 46             Shenzhen Dymind Biotechnology: Major Product Offerings

Table 47             Shenzhen iCubio Biomedical Technology: Major Product Offerings

Table 48             SHENZHEN PROKAN ELECTRONICS: Major Product Offerings

Table 49             SPINREACT: Major Product Offerings

Table 50             Trivitron Healthcare: Major Product Offerings

Table 51             Global Hematology Testing Market by Geography 2021−2027 ($ million)

Table 52             Global Hematology Testing Market by Geography 2021−2027 (%)

Table 53             Global Hematology Testing Market by End-User 2021−2027 ($ million)

Table 54             Global Hematology Testing Market by End-User 2021−2027 (%)

Table 55             Global Hematology Testing Market by Test 2021−2027 ($ million)

Table 56             Global Hematology Testing Market by Test 2021−2027 (%)

Table 57             Global Hematology Testing Market by Product 2021−2027 ($ million)

Table 58             Global Hematology Testing Market by Product 2021−2027 (%)

Table 59             Global Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 60             Global Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 61             Global Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 62             Global Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Table 63             North America Hematology Testing Market by End-User 2021−2027 ($ million)

Table 64             North America Hematology Testing Market by End-User 2021−2027 (%)

Table 65             North America Hematology Testing Market by Test 2021−2027 ($ million)

Table 66             North America Hematology Testing Market by Test 2021−2027 (%)

Table 67             North America Hematology Testing Market by Product 2021−2027 ($ million)

Table 68             North America Hematology Testing Market by Product 2021−2027 (%)

Table 69             North America Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 70             North America Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 71             North America Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 72             North America Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Table 73             Europe Hematology Testing Market by End-User 2021−2027 ($ million)

Table 74             Europe Hematology Testing Market by End-User 2021−2027 (%)

Table 75             Europe Hematology Testing Market by Test 2021−2027 ($ million)

Table 76             Europe Hematology Testing Market by Test 2021−2027 (%)

Table 77             Europe Hematology Testing Market by Product 2021−2027 ($ million)

Table 78             Europe Hematology Testing Market by Product 2021−2027 (%)

Table 79             Europe Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 80             Europe Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 81             Europe Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 82             Europe Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Table 83             APAC Hematology Testing Market by End-User 2021−2027 ($ million)

Table 84             APAC Hematology Testing Market by End-User 2021−2027 (%)

Table 85             APAC Hematology Testing Market by Test 2021−2027 ($ million)

Table 86             APAC Hematology Testing Market by Test 2021−2027 (%)

Table 87             APAC Hematology Testing Market by Product 2021−2027 ($ million)

Table 88             APAC Hematology Testing Market by Product 2021−2027 (%)

Table 89             APAC Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 90             APAC Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 91             APAC Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 92             APAC Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Table 93             Latin America Hematology Testing Market by End-User 2021−2027 ($ million)

Table 94             Latin America Hematology Testing Market by End-User 2021−2027 (%)

Table 95             Latin America Hematology Testing Market by Test 2021−2027 ($ million)

Table 96             Latin America Hematology Testing Market by Test 2021−2027 (%)

Table 97             Latin America Hematology Testing Market by Product 2021−2027 ($ million)

Table 98             Latin America Hematology Testing Market by Product 2021−2027 (%)

Table 99             Latin America Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 100           Latin America Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 101           Latin America Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 102           Latin America Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Table 103           Middle East & Africa Hematology Testing Market by End-User 2021−2027 ($ million)

Table 104           Middle East & Africa Hematology Testing Market by End-User 2021−2027 (%)

Table 105           Middle East & Africa Hematology Testing Market by Test 2021−2027 ($ million)

Table 106           Middle East & Africa Hematology Testing Market by Test 2021−2027 (%)

Table 107           Middle East & Africa Hematology Testing Market by Product 2021−2027 ($ million)

Table 108           Middle East & Africa Hematology Testing Market by Product 2021−2027 (%)

Table 109           Middle East & Africa Hematology Testing Market by Analyzers – Volume 2021−2027 ($ million)

Table 110           Middle East & Africa Hematology Testing Market by Analyzers – Volume 2021−2027 (%)

Table 111           Middle East & Africa Hematology Testing Market by Analyzers – Part Differential 2021−2027 ($ million)

Table 112           Middle East & Africa Hematology Testing Market by Analyzers – Part Differential 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date